Netrin-1 inhibitor blocks chemo resistance in pancreatic cancer

April 22, 2026

Netris Pharma SA has delivered positive phase Ib data showing its first-in-class netrin-1 inhibitor NP-137 alleviates resistance to chemotherapy in pancreatic cancer. This could represent an important advance in treating these tumors, which are notoriously resistant to chemotherapy.

Source: bioworld

Publication

The World Dispatch

Source: World News API

Keywords: bioworld, pembrolizumab, head and neck cancer, cancer, antibody, pancreatic cancer, keytruda, clinical, conferences, endometrial cancer, netrin-1, american association for cancer research, europe, checkpoint inhibitors, lung cancer, ONLY AVAILABLE IN PROFESSIONAL AND CORPORATE PLANS